Form 8-K - Current report:
SEC Accession No. 0001193125-18-319603
Filing Date
2018-11-06
Accepted
2018-11-06 16:25:06
Documents
3
Period of Report
2018-11-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d651511d8k.htm 8-K 25733
2 EX-2.2 d651511dex22.htm EX-2.2 27498
3 EX-2.4 d651511dex24.htm EX-2.4 109707
  Complete submission text file 0001193125-18-319603.txt   164219
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 181163325
SIC: 2836 Biological Products, (No Diagnostic Substances)